Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 180 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Kesimpta® (Ofatumumab) in Swiss Multiple Sclerosis Patients - an Observational Study

 		Multiple Sclerosis

A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Elevated hsCRP

 		Coronary Heart Disease Phase2

Ribociclib (LEE011) Rollover Study for Continued Access

 		Continued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies Phase2

Kesimpta (Ofatumumab) Pregnancy Registry

 		Multiple Sclerosis, Pregnancy

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

 		Systemic Lupus Erythematosus Phase3

Effectiveness and Safety of Dabrafenib in Combination With Trametinib as Adjuvant Treatment for Chinese Patients With Stage III BRAF V600 Mutation-positive Melanoma After Complete Resection

 		Melanoma

A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas

 		Metastatic Uveal Melanoma Phase1, Phase2

A NIS Evaluating Injectable Treatments in Patients With Relapsing Multiple Sclerosis

 		Relapsing Multiple Sclerosis

A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia

 		Warm Autoimmune Hemolytic Anemia (wAIHA) Phase3

Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan

 		Prostate Cancer Phase2